These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 11686231)

  • 1. Helicobacter pylori eradication in functional dyspepsia: new evidence for symptomatic benefit.
    Malfertheiner P
    Eur J Gastroenterol Hepatol; 2001 Aug; 13 Suppl 2():S9-11. PubMed ID: 11686231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key topics in Helicobacter pylori eradication in the management of the dyspeptic patient: a panel discussion.
    Kearney DJ; Mégraud F
    Eur J Gastroenterol Hepatol; 2001 Aug; 13 Suppl 2():S17-21. PubMed ID: 11686229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.
    Veldhuyzen van Zanten S; Fedorak RN; Lambert J; Cohen L; Vanjaka A
    Am J Gastroenterol; 2003 Sep; 98(9):1963-9. PubMed ID: 14499772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
    Koskenpato J; Färkkilä M; Sipponen P
    Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
    Koskenpato J; Farkkilä M; Sipponen P
    Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
    Lara LF; Cisneros G; Gurney M; Van Ness M; Jarjoura D; Moauro B; Polen A; Rutecki G; Whittier F
    Arch Intern Med; 2003 Sep; 163(17):2079-84. PubMed ID: 14504122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.
    Oderda G; Marinello D; Lerro P; Kuvidi M; de'Angelis GL; Ferzetti A; Cucchiara S; Franco MT; Romano C; Strisciuglio P; Pensabene L
    Helicobacter; 2004 Aug; 9(4):293-301. PubMed ID: 15270743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the symptomatology and quality of life in functional dyspepsia before and after Helicobacter pylori eradication treatment].
    Ladrón de Guevara L; Peña-Alfaro NG; Padilla L; Lichtinger A; Figueroa S; Shapiro I; Rubinstein M; Di Silvio M
    Rev Gastroenterol Mex; 2004; 69(4):203-8. PubMed ID: 15765971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial.
    Ott EA; Mazzoleni LE; Edelweiss MI; Sander GB; Wortmann AC; Theil AL; Somm G; Cartell A; Rivero LF; Uchôa DM; Francesconi CF; Prolla JC
    Aliment Pharmacol Ther; 2005 May; 21(10):1231-9. PubMed ID: 15882244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori eradication lowers esophageal sphincter pressures in functional dyspepsia patients.
    Besisik F; Sürücü F; Mungan Z; Dinçer D; Kapran Y; Kaymakoglu S; Cevikbas U
    Hepatogastroenterology; 2001; 48(42):1772-5. PubMed ID: 11813622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
    Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM
    Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of Helicobacter pylori infection in the management of patients with dyspepsia and non-ulcer dyspepsia.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1998; 71(2):125-33. PubMed ID: 10378358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key points from the revised Maastricht Consensus Report: the impact on general practice.
    Bazzoli F
    Eur J Gastroenterol Hepatol; 2001 Aug; 13 Suppl 2():S3-7. PubMed ID: 11686230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is nonulcer dyspepsia related to Helicobacter pylori infection?
    Fennerty MB
    Semin Gastrointest Dis; 2001 Jul; 12(3):180-5. PubMed ID: 11478750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gastritis, dyspepsia and Helicobacter pylori].
    de Korwin JD
    Rev Prat; 2000 Sep; 50(13):1431-6. PubMed ID: 11019635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study.
    Mazzoleni LE; Sander GB; Ott EA; Barros SG; Francesconi CF; Polanczyk CA; Wortmann AC; Theil AL; Fritscher LG; Rivero LF; Cartell A; Edelweiss MI; Uchôa DM; Prolla JC
    Dig Dis Sci; 2006 Jan; 51(1):89-98. PubMed ID: 16416218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.